Yongmei Xu

Title: Innovations and Contributions of Inventor Yongmei Xu

Introduction

Yongmei Xu is a prominent inventor based in Durham, NC (US), known for her significant contributions to the field of biomedical research. With a total of five patents to her name, she has made remarkable strides in developing compounds with therapeutic applications.

Latest Patents

One of her latest patents is focused on sulfated oligosaccharides having anti-inflammatory activity. This patent provides small molecule compounds, including non-anticoagulant heparan sulfate oligosaccharide molecules, which possess anti-inflammatory properties. These compounds are capable of interacting with high mobility group box 1 (HMGB1) proteins, influencing their interaction with receptors for advanced glycation end products (RAGE). Additionally, methods for treating Paracetamol (APAP) overdose in subjects are included in this patent. Another notable patent involves short-acting heparin-based anticoagulant compounds. This patent details heparin compounds and synthetic heparin analogues that exhibit short-acting anticoagulant activity. It also outlines methods for synthesizing these heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes, and methods for treating subjects in need of anticoagulant activity.

Career Highlights

Yongmei Xu has worked at esteemed institutions such as the University of North Carolina at Chapel Hill and the State University of New York. Her work at these institutions has contributed to her expertise and innovation in the field of biomedical research.

Collaborations

Throughout her career, Yongmei has collaborated with notable colleagues, including Jian Liu and Ding Xu. These collaborations have further enhanced her research and development efforts.

Conclusion

Yongmei Xu's innovative work and patents reflect her dedication to advancing biomedical research and developing therapeutic solutions. Her contributions continue to impact the field positively.